Washington, DC – Today, Ways and Means Committee Chairman Dave Camp (R-MI) issued the following statement in response to CMS’ announcement that it would not finalize certain rules related to Medicare Part D prescription drug plans.

“I appreciate that CMS Administrator Marilyn Tavenner will not finalize controversial provisions of the proposed Part D rule.  It was clear from the overwhelming number of comments from seniors, advocacy groups, Part D plans and Members of Congress that CMS’ proposal would significantly alter the Part D program and could put in jeopardy seniors’ access to affordable medications.  While this announcement provides limited relief in the short-term, it should lay the groundwork for strong bipartisan support for legislation expressing Congress’ disapproval of these proposals.  As Part D approaches a decade of providing access to affordable prescriptions for seniors, Congress must redouble its efforts to work with all parties to ensure the long-term viability of the successful Part D program.”